1. Rahman S, Islam S, Haque T, Kathak RR, Ali N. Association between serum liver enzymes and hypertension: a cross-sectional study in Bangladeshi adults. BMC Cardiovasc Disord 2020;20:1-7. [
DOI:10.1186/s12872-020-01411-6] [
PMID] [
]
2. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14(S5):S7-85. https://doi.org/10.1002/(SICI)1096-9136(199712)14:5+
3.0.CO;2-R
https://doi.org/10.1002/(SICI)1096-9136(199712)14:5+3.0.CO;2-R [DOI:10.1002/(SICI)1096-9136(199712)14:5+3.0.CO;2-R] 3. Leevy CM, Ryan CM, Fineberg JC. Diabetes mellitus and liver dysfunction; etiologic and therapeutic considerations. Am J Med 1950;8(3):290-9. [
DOI:10.1016/0002-9343(50)90062-3] [
PMID]
4. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23(2):201-29. http://dx.doi.org/10.1210/edrv.23.2.0461. [
DOI:10.1210/edrv.23.2.0461] [
PMID]
5. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018;14(2):88-98. http://dx.doi.org/10.1038/nrendo.2017.151. [
DOI:10.1038/nrendo.2017.151] [
PMID]
6. Hanley AJG, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2004;53(10):2623-32. [
DOI:10.2337/diabetes.53.10.2623] [
PMID]
7. Kim DJ, Noh JH, Cho NH, Lee BW, Choi YH, Jung JH, et al. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabet Med 2005;22(9):1134-40. [
DOI:10.1111/j.1464-5491.2005.01581.x] [
PMID]
8. Harris EH. Elevated liver function tests in type 2 diabetes. Clin Diabetes 2005;23(3):115-9. [
DOI:10.2337/diaclin.23.3.115]
9. Seifu Daniel ZB. Impairment of liver function tests and lipid profiles in type 2 diabetic patients treated at the diabetic center in Tikur Anbessa specialized teaching hospital (tasth), Addis Ababa, Ethiopia. J Diabetes Metab 2014;5(11). [
DOI:10.4172/2155-6156.1000454]
10. Erbey JR, Silberman C, Lydick E. Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. Am J Med 2000;109(7):588-90. [
DOI:10.1016/S0002-9343(00)00602-1] [
PMID]
11. Meybodi MA, Afkhami-Ardekani M, Rashidi M. Prevalence of abnormal serum alanine aminotransferase levels in type 2 diabetic patients in Iran. Pak J Biol Sci 2008;11(18):2274-7. [
DOI:10.3923/pjbs.2008.2274.2277] [
PMID]
12. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997;26(1):143-6. [
DOI:10.1002/hep.510260119] [
PMID]
13. Stranges S, Trevisan M, Dorn JM, Dmochowski J, Donahue RP. Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study: Evidence from the western New York study. Hypertension 2005;46(5):1186-93. [
DOI:10.1161/01.HYP.0000185688.81320.4d] [
PMID] [
]
14. Gyawali B, Ferrario A, van Teijlingen E, Kallestrup P. Challenges in diabetes mellitus type 2 management in Nepal: a literature review. Glob Health Action 2016;9(1):31704. [
DOI:10.3402/gha.v9.31704] [
PMID] [
]
15. Teshome G, Ambachew S, Fasil A, Abebe M. Prevalence of liver function test abnormality and associated factors in Type 2 Diabetes Mellitus: A comparative cross-sectional study. Electron. J Int Fed Clin Chem Lab Med 2019;30(3):303-16. [
PMID]
16. Takhelmayum R, Thanpari C, Singh TP. Liver dysfunction in diabetic patients admitted in referral hospital. Bali Med J 2014;3(3):122-4. [
DOI:10.15562/bmj.v3i3.87]
17. Ghimire S, Shakya S, Shakya J, Acharya P, Pardhe BD. Abnormal liver parameters among individuals with type 2 diabetes mellitus Nepalese population. Biochem Pharmacol (Los Angel) 2018;7(1):2167-501. [
DOI:10.4172/2167-0501.1000243]
18. Ni H, Soe HH, Htet A. Determinants of abnormal liver function tests in diabetes patients in Myanmar. Int J Diabetes Res 2012;1(3):36-41. [
DOI:10.5923/j.diabetes.20120103.02]
19. Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes. Medicine 1996;75(6):327-33. [
DOI:10.1097/00005792-199611000-00003] [
PMID]
20. Jha SK, Yadav NK, Rizal S. Prevalence of elevated liver enzymes and its association with type 2 diabetes: A Descriptive Cross-Sectional Study among Nepalese Adults from Biratnagar, Nepal. Asian J Med Sci 2021;12(6):50-5. [
DOI:10.3126/ajms.v12i6.37074]
21. Al-Jameil N, Khan FA, Arjumand S, Khan MF, Tabassum H. Dyslipidemia and its correlation with type 2 diabetic patients at different stages of proteinuria. Biomed Res 2014;25(3):327-31. [
Google Scholar]
22. Thanpari C, Yadav N, Takhelmayum R, Shrewastwa M, Thapa P. Status of antioxidant and liver function in type-2 diabetic patients attending Nepalgunj Medical College. Bali Med J 2013;2:1-4. [
URL]
23. Bora K, Borah M, Chutia H, Nath CK, Das D, Ruram AA. Presence of concurrent derangements of liver function tests in type 2 diabetes and their relationship with glycemic status: A retrospective observational study from Meghalaya. J Lab Physicians 2016;8(01):030-5. [
DOI:10.4103/0974-2727.176227] [
PMID] [
]
24. Balogun WO, Adeleye JO, Akinlade KS, Adedapo KS, Kuti M. Frequent occurrence of high gamma-glutamyl transferase and alanine amino transferase among Nigerian patients with type 2 diabetes. Afr J Med Med Sci 2008;37(2):177-83. [
Google Scholar]